Страна: Ирландия
Език: английски
Източник: HPRA (Health Products Regulatory Authority)
GLUCOSAMINE SULFATE SODIUM CHLORIDE
AHA Medical Services Ltd
M01AX05
GLUCOSAMINE SULFATE SODIUM CHLORIDE
1500 Milligram
Film Coated Tablet
Product not subject to medical prescription
Other antiinflammatory and antirheumatic agents, non-steroids
Authorised
2013-11-25
FRONT416. FURTHER INFORMATION What Doloritis contains The active substance is glucosamine sulfate. One tablet contains 1884.60 mg of glucosamine sulfate sodium chloride equivalent to 1500 mg glucosamine sulfate or 1178 mg glucosamine. The other ingredients are Core tablet Povidone K30 Macrogol 4000 Magnesium Stearate Coating material Hypromellose Titanium Dioxide (E171) Talc Propylene glycol Polysorbate 80 What Doloritis looks like and contents of the pack Doloritis is a white to off white, oval shaped, bi-convex film-coated tablet with break line on one side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. Pack-sizes: 20, 30, 60 or 90 film-coated tablets in a HDPE bottles with HDPE screw cap. 2, 4, 10, 20, 30, 45, 60, 90, 180 film coated tablets in Alu/PVC/PVDC blister packs. Not all pack sizes may be marketed. Marketing Authorisation Holder AHA Medical Services Ltd 6 Cathedral Park, Belmont Industrial Estate, Durham, DH1 1TF United Kingdom. Doloritis1500 mg film-coated tablets Glucosamine sulfateRead all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you still need to take Doloritis carefully to get the best results from it. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. You must contact a doctor if your symptoms worsen or do not improve after 2 to 3 months. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What Doloritis is and what it is used for 2. Before you take Doloritis 3. How to take Doloritis 4. Possible side effects 5. How to store Doloritis 6. Further information 1. WHAT DOLORITIS IS AND WHAT IT IS USED FOR Doloritis 1500 mg film-coated tablets belong to the group of other anti-inflammatory and anti-rheumatic agents, non-steroids. Glucosamine is a substance natural Прочетете целия документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Doloritis 1500 mg Film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains 1884.60 mg of glucosamine sulfate sodium chloride equivalent to 1500 mg glucosamine sulfate or 1178 mg glucosamine. 'Excipient with known effect: Sodium 151mg per tablet'. For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film-coated tablet White to off white, oval shaped, bi-convex film-coated tablets with breakline on one side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS In management of chronic knee stiffness and pain after periods of immobility. Doloritis 1500mg film-coated tablets are also used in Osteoarthritis, as pre-diagnosed by a doctor. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _ADULTS:_ One tablet daily Glucosamine is not indicated for the treatment of acute painful symptoms. Relief of symptoms (especially pain relief) may not be experienced until after several weeks of treatment and in some cases even longer. If no relief of symptoms is experienced after 2-3 months, the patient should consult their doctor and continued treatment with glucosamine should be re-evaluated. Tablets can be taken with or without food. Additional information on special populations: _ELDERLY:_ No specific studies have been performed in the elderly, but according to clinical experience dosage adjustment is not required when treating otherwise healthy, elderly patients. _CHILDREN AND ADOLESCENTS:_ Doloritis 1500 mg film-coated tablets are not recommended for use in children and adolescents below the age of 18 years, due to lack of data on safety and efficacy. _IMPAIRED RENAL AND/ Прочетете целия документ